MitoQ alleviates m.3243A>G-induced mitochondrial dysfunction by stabilizing PINK1 and enhancing mitophagy

Area of Science:

• Mitochondrial biology
• Neuroscience
• Stem cell research

Background:

• The mitochondrial 3243A>G mutation (m.3243A>G) is linked to various clinical conditions.
• Understanding the mechanisms behind m.3243A>G is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the cellular and organismal effects of the m.3243A>G mutation.
• To explore the therapeutic potential of MitoQ in models of m.3243A>G.

Main Methods:

• Utilized patient-derived urine-derived stem cells (USCs) and a Caenorhabditis elegans (C. elegans) model with mitochondrial leucyl-tRNA synthetase (lars-2) deficiency.
• Assessed mitochondrial homeostasis, dynamics, mitophagy, and neuromuscular function.
• Investigated the role of OMA1-PINK1 pathway in response to m.3243A>G and MitoQ treatment.

Main Results:

• Patient-derived USCs with high m.3243A>G heteroplasmy showed impaired mitochondrial function, disrupted dynamics, and reduced mitophagy.
• MitoQ reversed these deficits in USCs by suppressing OMA1-mediated PINK1 degradation.
• The C. elegans model exhibited mitochondrial stress and neuromuscular dysfunction mimicking m.3243A>G phenotypes.
• MitoQ partially restored neurobehavioral function in C. elegans via the PINK1 pathway.

Conclusions:

• Mitochondrial dysfunction and neuromuscular deficits are key features of the m.3243A>G mutation.
• MitoQ demonstrates therapeutic potential for m.3243A>G-associated conditions by modulating mitochondrial quality control pathways.